Replimune

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$4.92-$17
Market Cap
$961.1M
Shares Short
5M

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$3.04

News

See more

Yahoo Finance • 2 months ago

Morgan Stanley's Strategic Reduction in Replimune Group Inc Holdings

Yahoo Finance • 11 months ago

15 Small-Cap Stocks with High Potential

Yahoo Finance • 12 months ago

Replimune to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Yahoo Finance • last year

Replimune Shares Initial Primary Analysis Results from CERPASS Clinical Trial in Advanced Cutaneous Squamous Cell Carcinoma and Presents New Data from IGNYTE Clinical Trial of RP1 in Anti-PD1 Failed Melanoma and Non-Melanoma Skin Cancers

About

CEO
Dr. Sushil Patel Ph.D.
Address
500 Unicorn Park Drive, Woburn, MA, United States, 01801
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
331